• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发育停滞:肿瘤微环境中自然杀伤细胞功能的抑制

Arrested development: suppression of NK cell function in the tumor microenvironment.

作者信息

Riggan Luke, Shah Siya, O'Sullivan Timothy E

机构信息

Department of Microbiology, Immunology, and Molecular Genetics David Geffen School of Medicine at UCLA Los Angeles CA USA.

Molecular Biology Institute University of California Los Angeles CA USA.

出版信息

Clin Transl Immunology. 2021 Jan 10;10(1):e1238. doi: 10.1002/cti2.1238. eCollection 2021.

DOI:10.1002/cti2.1238
PMID:33456775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7797224/
Abstract

Natural killer (NK) cells are cytotoxic innate lymphocytes that protect against viral infection and tumor metastasis. Despite their inherent ability to kill a broad range of virally infected, stressed and transformed cells, low numbers of dysfunctional NK cells are often observed in many advanced solid human cancers. Here, we review the potential mechanisms that influence suboptimal mature NK cell recruitment and function in the tumor microenvironment (TME) of solid tumors. We further highlight current immunotherapy approaches aimed to circumvent NK cell dysfunction and discuss next-generation strategies to enhance adoptive NK cell therapy through targeting intrinsic and extrinsic checkpoints the regulate NK cell functionality in the TME. Understanding the mechanisms that drive NK cell dysfunction in the TME will lead to novel immunotherapeutic approaches in the fight against cancer.

摘要

自然杀伤(NK)细胞是具有细胞毒性的先天性淋巴细胞,可抵御病毒感染和肿瘤转移。尽管它们具有杀死多种病毒感染、应激和转化细胞的内在能力,但在许多晚期人类实体癌中,常常观察到功能失调的NK细胞数量较少。在这里,我们综述了影响实体瘤肿瘤微环境(TME)中成熟NK细胞募集和功能欠佳的潜在机制。我们进一步强调了旨在规避NK细胞功能障碍的当前免疫治疗方法,并讨论了通过靶向调节TME中NK细胞功能的内在和外在检查点来增强过继性NK细胞治疗的下一代策略。了解驱动TME中NK细胞功能障碍的机制将为对抗癌症带来新的免疫治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1234/7797224/5de025a5a4bf/CTI2-10-e1238-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1234/7797224/789cb6c7a528/CTI2-10-e1238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1234/7797224/1dc04fdfcc59/CTI2-10-e1238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1234/7797224/a21e0378abf7/CTI2-10-e1238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1234/7797224/14c830f0419c/CTI2-10-e1238-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1234/7797224/5de025a5a4bf/CTI2-10-e1238-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1234/7797224/789cb6c7a528/CTI2-10-e1238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1234/7797224/1dc04fdfcc59/CTI2-10-e1238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1234/7797224/a21e0378abf7/CTI2-10-e1238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1234/7797224/14c830f0419c/CTI2-10-e1238-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1234/7797224/5de025a5a4bf/CTI2-10-e1238-g005.jpg

相似文献

1
Arrested development: suppression of NK cell function in the tumor microenvironment.发育停滞:肿瘤微环境中自然杀伤细胞功能的抑制
Clin Transl Immunology. 2021 Jan 10;10(1):e1238. doi: 10.1002/cti2.1238. eCollection 2021.
2
Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment.绘制通往实体瘤的杀伤性路线:在肿瘤微环境中招募和激活自然杀伤细胞的策略。
Front Immunol. 2023 Nov 8;14:1286750. doi: 10.3389/fimmu.2023.1286750. eCollection 2023.
3
Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors.靶向免疫检查点:如何利用自然杀伤细胞对抗实体瘤。
Cancer Commun (Lond). 2023 Feb;43(2):177-213. doi: 10.1002/cac2.12394. Epub 2022 Dec 30.
4
Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?在肿瘤微环境中释放自然杀伤细胞——下一代免疫疗法?
Front Immunol. 2020 Feb 21;11:275. doi: 10.3389/fimmu.2020.00275. eCollection 2020.
5
Targeting Natural Killer Cells for Tumor Immunotherapy.靶向自然杀伤细胞进行肿瘤免疫治疗。
Front Immunol. 2020 Feb 19;11:60. doi: 10.3389/fimmu.2020.00060. eCollection 2020.
6
Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment.基于自然杀伤细胞的免疫疗法设计与实施以克服实体瘤微环境
Cancers (Basel). 2020 Dec 21;12(12):3871. doi: 10.3390/cancers12123871.
7
Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy.自然杀伤细胞功能障碍与癌症及利用 NK 细胞潜力进行癌症免疫治疗的新策略。
Mol Immunol. 2022 Apr;144:58-70. doi: 10.1016/j.molimm.2022.02.015. Epub 2022 Feb 21.
8
Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.靶向肿瘤微环境中自然杀伤细胞-髓系细胞轴的治疗方法。
Front Immunol. 2021 Apr 19;12:633685. doi: 10.3389/fimmu.2021.633685. eCollection 2021.
9
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies.自然杀伤细胞的病毒和非病毒工程作为新兴的过继性癌症免疫疗法。
J Immunol Res. 2018 Sep 17;2018:4054815. doi: 10.1155/2018/4054815. eCollection 2018.
10
Next Generation Natural Killer Cells for Cancer Immunotherapy.下一代自然杀伤细胞用于癌症免疫治疗。
Front Immunol. 2022 Jun 2;13:886429. doi: 10.3389/fimmu.2022.886429. eCollection 2022.

引用本文的文献

1
Nanotechnology and natural killer cell immunotherapy: synergistic approaches for precise immune system adjustment and targeted cancer treatment in gastrointestinal tumors.纳米技术与自然杀伤细胞免疫疗法:胃肠道肿瘤中精确调节免疫系统和靶向癌症治疗的协同方法。
Front Med (Lausanne). 2025 Aug 21;12:1647737. doi: 10.3389/fmed.2025.1647737. eCollection 2025.
2
Immune profiling of pediatric germ cell tumors identifies key cell populations and novel therapeutic targets.儿童生殖细胞肿瘤的免疫图谱分析确定了关键细胞群和新的治疗靶点。
Front Immunol. 2025 Jun 20;16:1579948. doi: 10.3389/fimmu.2025.1579948. eCollection 2025.
3

本文引用的文献

1
Drug target validation in primary human natural killer cells using CRISPR RNP.利用 CRISPR RNP 在原代人自然杀伤细胞中进行药物靶标验证。
J Leukoc Biol. 2020 Oct;108(4):1397-1408. doi: 10.1002/JLB.2MA0620-074R. Epub 2020 Jul 17.
2
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade.树突状细胞上的 PD-L1 可减弱 T 细胞的激活,并调节对免疫检查点阻断的反应。
Nat Commun. 2020 Sep 24;11(1):4835. doi: 10.1038/s41467-020-18570-x.
3
CAR-NK cells: A promising cellular immunotherapy for cancer.
CAR-NK cell therapy: promise and challenges in solid tumors.
嵌合抗原受体自然杀伤细胞(CAR-NK)疗法:实体瘤治疗中的前景与挑战
Front Immunol. 2025 Apr 7;16:1574742. doi: 10.3389/fimmu.2025.1574742. eCollection 2025.
4
An intraepithelial ILC1-like natural killer cell subset produces IL-13.一种上皮内类似ILC1的自然杀伤细胞亚群可产生白细胞介素-13。
Front Immunol. 2025 Mar 6;16:1521086. doi: 10.3389/fimmu.2025.1521086. eCollection 2025.
5
Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors.嵌合抗原受体细胞疗法:为实体瘤治疗策略赋能。
Curr Issues Mol Biol. 2025 Jan 31;47(2):90. doi: 10.3390/cimb47020090.
6
Nuclear EGFR in breast cancer suppresses NK cell recruitment and cytotoxicity.乳腺癌中的细胞核表皮生长因子受体抑制自然杀伤细胞的募集和细胞毒性。
Oncogene. 2025 Feb;44(5):288-295. doi: 10.1038/s41388-024-03211-0. Epub 2024 Nov 9.
7
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside.嵌合抗原受体自然杀伤细胞治疗胃肠道肿瘤免疫治疗:从基础到临床。
Mol Cancer. 2024 Oct 23;23(1):237. doi: 10.1186/s12943-024-02151-3.
8
Advances in CAR-NK cell therapy for hematological malignancies.嵌合抗原受体自然杀伤细胞疗法治疗血液系统恶性肿瘤的研究进展。
Front Immunol. 2024 Jun 28;15:1414264. doi: 10.3389/fimmu.2024.1414264. eCollection 2024.
9
Rice bran arabinoxylan compound as a natural product for cancer treatment - an evidence-based assessment of the effects and mechanisms.米糠阿拉伯木聚糖复合物作为一种天然产物用于癌症治疗——对作用机制和效果的循证评估。
Pharm Biol. 2024 Dec;62(1):367-393. doi: 10.1080/13880209.2024.2349042. Epub 2024 May 15.
10
Therapeutic approaches to enhance natural killer cell cytotoxicity.增强自然杀伤细胞细胞毒性的治疗方法。
Front Immunol. 2024 Mar 11;15:1356666. doi: 10.3389/fimmu.2024.1356666. eCollection 2024.
嵌合抗原受体自然杀伤细胞:癌症有前途的细胞免疫疗法。
EBioMedicine. 2020 Sep;59:102975. doi: 10.1016/j.ebiom.2020.102975. Epub 2020 Aug 24.
4
Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy.针对自然杀伤细胞检查点受体或分子的癌症免疫治疗。
Front Immunol. 2020 Jun 23;11:1295. doi: 10.3389/fimmu.2020.01295. eCollection 2020.
5
The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.NK 细胞-肿瘤周期:基于 NK 细胞的免疫疗法的进展和新挑战。
Nat Immunol. 2020 Aug;21(8):835-847. doi: 10.1038/s41590-020-0728-z. Epub 2020 Jul 20.
6
The cancer-natural killer cell immunity cycle.癌症-自然杀伤细胞免疫周期。
Nat Rev Cancer. 2020 Aug;20(8):437-454. doi: 10.1038/s41568-020-0272-z. Epub 2020 Jun 24.
7
Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity.通过删除人诱导多能干细胞衍生 NK 细胞中的 CISH 实现代谢重编程促进体内持久性并增强抗肿瘤活性。
Cell Stem Cell. 2020 Aug 6;27(2):224-237.e6. doi: 10.1016/j.stem.2020.05.008. Epub 2020 Jun 11.
8
Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins.利用 Cas9 核糖核蛋白进行 CRISPR 基因组工程增强 NK-92 细胞的细胞毒性。
Front Immunol. 2020 May 22;11:1008. doi: 10.3389/fimmu.2020.01008. eCollection 2020.
9
MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignancies.MYC 作为自然杀伤细胞介导的淋巴恶性肿瘤免疫监视的开关发挥作用。
Nat Commun. 2020 Jun 5;11(1):2860. doi: 10.1038/s41467-020-16447-7.
10
Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity.肿瘤浸润 NK 细胞的单细胞 RNA 测序揭示,转录因子 HIF-1α 的抑制可释放 NK 细胞活性。
Immunity. 2020 Jun 16;52(6):1075-1087.e8. doi: 10.1016/j.immuni.2020.05.001. Epub 2020 May 22.